Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted modelsJames G. Taylor, Javed Khan, Adam Cheuk et al.|Journal of Clinical Investigation|2009Cited by 322
The MYCN oncogene is a direct target of miR-34aJun S. Wei, Javed Khan, Young Song et al.|Oncogene|2008Cited by 297
Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534)Samuel Q. Li, Javed Khan, Adam Cheuk et al.|PLoS ONE|2013Cited by 100
Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34aQingrong Chen, Javed Khan, Li‐Rong Yu et al.|Journal of Proteome Research|2010Cited by 86
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastomaMeijie Tian, Javed Khan, Adam Cheuk et al.|Journal of Clinical Investigation|2022Cited by 72